Higher drug doses tested for Tough-to-Treat arthritis
NCT ID NCT00691028
Summary
This study tested whether giving higher doses of the drug infliximab, along with methotrexate, could better control rheumatoid arthritis in patients who weren't responding well to standard treatment. Researchers compared three different dose levels over 54 weeks in 327 patients. The goal was to see if higher doses reduced joint pain and swelling more effectively while remaining safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.